The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development-Reference-Cited by-同舟云学术

The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development

Published:2019-06-14 Issue:7 Volume:16 Page:593-600
ISSN:1478-9450
Container-title:Expert Review of Proteomics
language:en
Short-container-title:Expert Review of Proteomics

Author:

Baldacci Filippo¹²³⁴,Lista Simone²³⁴,Palermo Giovanni¹,Giorgi Filippo Sean¹,Vergallo Andrea²³⁴,Hampel Harald²

Affiliation:

1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

2. Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l’hôpital, F-75013, Paris, France

3. Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l’hôpital, F-75013, Paris, France

4. Institute of Memory and Alzheimer’s Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l’hôpital, F-75013, Paris, France

Funder

AXA Research fund, the ‘Fondation partenariale Sorbonne Université’

‘Fondation pour la Recherche sur Alzheimer’

French government ‘Investissements d’avenir’

Publisher

Informa UK Limited

Subject

Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/14789450.2019.1628643

Reference84 articles.

1. Neuroinflammation in Alzheimer's disease